GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.4X leverage
Performance
- Low
- ₹2,014
- High
- ₹2,055
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,050
- Previous Close₹2,047
- Volume579,266
Investment Returns
- Over 1 Month + 9.65%
- Over 3 Month + 0.07%
- Over 6 Month + 20.02%
- Over 1 Year + 31.53%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.5
- PEG Ratio
- 0.3
- Market Cap Cr
- 57,007
- P/B Ratio
- 5.9
- Average True Range
- 42.9
- EPS
- 89.11
- Dividend Yield
- 0.2
- MACD Signal
- 24.55
- RSI
- 61.99
- MFI
- 53.19
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,020.10
-26.9
(-1.31%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,968.45
- 50 Day
- ₹1,939.48
- 100 Day
- ₹1,909.74
- 200 Day
- ₹1,812.43
Resistance and Support
2029.6
- R3 2,086.50
- R2 2,070.70
- R1 2,045.40
- S1 2,004.30
- S2 1,988.50
- S3 1,963.20
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,020 As on 25 December, 2025 | 09:59
The Market Cap of Glenmark Pharmaceuticals is ₹57007.4 Cr As on 25 December, 2025 | 09:59
The P/E ratio of Glenmark Pharmaceuticals is 56.5 As on 25 December, 2025 | 09:59
The PB ratio of Glenmark Pharmaceuticals is 5.9 As on 25 December, 2025 | 09:59
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.